does glp 1 affect kidneys Glucagon-Like Peptide-1 Receptor Agonist Use in People Living with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Narrative Review of the Key Evidence with Practical Considerations | Diabetes Therapy Role of GLP-1 Agonists &

However, whether there is a connection remains uncertain

While the study concluded that short-term DSIP treatment was unlikely to be of major therapeutic benefit noting that statistically significant effects were weak and partly attributable to incidental placebo group change it provided the most methodologically rigorous human sleep architecture dataset for DSIP and confirmed the compounds specific effect on objective, not merely subjective, sleep quality parameters

It is an investigational compound, not an FDA-approved medication

The platform connects individuals with licensed healthcare providers for medical consultations

MK-677 Oral Key Health Benefits: Enhanced Muscle Growth and Recovery